Raymond James & Associates cut its position in shares of Waters Co. (NYSE:WAT – Free Report) by 5.2% during the third quarter, Holdings Channel.com reports. The firm owned 97,863 shares of the medical instruments supplier’s stock after selling 5,396 shares during the quarter. Raymond James & Associates’ holdings in Waters were worth $35,220,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. raised its stake in Waters by 170.6% during the third quarter. Blue Trust Inc. now owns 322 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 203 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Waters by 2.0% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 6,250 shares of the medical instruments supplier’s stock worth $2,249,000 after buying an additional 124 shares during the period. Bleakley Financial Group LLC purchased a new stake in Waters during the 3rd quarter worth approximately $216,000. Global Retirement Partners LLC increased its stake in Waters by 34.7% during the 3rd quarter. Global Retirement Partners LLC now owns 1,329 shares of the medical instruments supplier’s stock worth $478,000 after buying an additional 342 shares during the period. Finally, Vontobel Holding Ltd. increased its stake in Waters by 1.4% during the 3rd quarter. Vontobel Holding Ltd. now owns 2,782 shares of the medical instruments supplier’s stock worth $1,001,000 after buying an additional 39 shares during the period. 94.01% of the stock is owned by hedge funds and other institutional investors.
Waters Price Performance
Shares of NYSE WAT opened at $333.28 on Thursday. Waters Co. has a twelve month low of $231.90 and a twelve month high of $367.21. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. The company has a market capitalization of $19.77 billion, a price-to-earnings ratio of 32.71, a PEG ratio of 6.85 and a beta of 0.95. The firm has a 50-day moving average of $342.79 and a two-hundred day moving average of $325.06.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on WAT. Cfra set a $389.00 target price on shares of Waters in a research note on Thursday, October 17th. Barclays increased their price objective on shares of Waters from $300.00 to $330.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. Leerink Partnrs raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. Wells Fargo & Company started coverage on shares of Waters in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $380.00 target price on the stock. Finally, Leerink Partners upgraded shares of Waters from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $325.00 to $375.00 in a research note on Thursday, August 1st. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Waters currently has an average rating of “Hold” and a consensus target price of $342.58.
View Our Latest Report on Waters
Waters Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More
- Five stocks we like better than Waters
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Health Care Stocks Explained: Why You Might Want to Invest
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Using the MarketBeat Dividend Tax Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.